National Press Club

529 14th St. NW 

Washington, DC 20045

Alzheimer’s disease affects about 55 million people worldwide, including 6.5 million Americans, and has no cure. Some patients with Alzheimer's sometimes show signs of extreme aggression or become restless and anxious as their brains lose the ability to negotiate with new stimulus. 
 
Agitation is a common neuropsychiatric symptom in Alzheimer’s dementia and one of the most complex and stressful aspects of caring for people living with the condition. It is reported in approximately half of people with Alzheimer’s dementia and is associated with earlier alternative living placement. 
 
What do patients, caregivers and families navigating the complexities of agitation associated with Alzheimer’s need to know? How are researchers and doctors better understanding risk factors and diagnoses? What policy actions can prioritize research, detection and treatment? And what are the access considerations for patients and their caregivers as they navigate this difficult symptom? 
 
The Hill will bring together caregivers, patients, clinical experts, and lawmakers to answer these questions and more as we discuss the fight against Alzheimer’s and breakthroughs in providing relief to those who suffer from agitation and aggression.